Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Received IDE approval from FDA to initiate the CGUARDIANS III clinical trial of its SwitchGuard ...
Q1 2026 Earnings Call April 29, 2026 8:00 PM EDTCompany ParticipantsKevin Burke - President, CEO & ChairmanJeffrey Miller ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results